Alberta’s premier says a decision this week by British health officials is in line with her government’s plans on transgender healthcare. Under a new policy, U.K. patients under the age of 18 will no longer be able to access puberty blockers unless they enroll in a clinical trial. That decision follows a four year review of published research, but critics say politics are at play. Heather Yourex-West reports.
Danielle Smith
Danielle Smith says U.K. decision to limit access to puberty blockers is example for Alberta
More Videos
-
Alberta’s Bill 20 includes bold steps to address housing crisis
-
Alberta’s Bill 20 criticized for voting changes
-
Political analyst expects municipal political parties if Bill 20 passes
-
Alberta Municipalities speaks out over province’s Bill 20 to have more control over local politics
-
Alberta announces plans for future passenger rail service
-
Global National: April 28
You are viewing an Accelerated Mobile Webpage.
View Original Article